- 'Black Swan' Shuns Public Life Because of Bernanke
- Look Ahead: Markets Count Down to US Jobs Report
- FHA to Toughen Mortgage Rules in Lenders Crackdown
- Obama to Send More Troops; Seeks Afghanistan Exit
- GM Removes CEO Henderson; Whitacre Is Interim Chief
- UK Economy Turned, Inflation to Spike: BoE Economist
- Who Were the Biggest Winners And Losers This Year?
- GE, Comcast Complete Deal Over NBC Universal: Source
- Case Closed but Woods Scrutiny Continues
- Unemployment to Peak at 10.5%: Moody's Economist
- 8 Stocks to Gain on Obama's Afghan Plan: Analysts
- BofA On Proposed Changes In The Housing Bailout Program
- The Future of The Media Landscape
- November Auto Sales Muddle Along
- Busch: What Obama Won't Say Tonight
- Stick with Equities—Avoid Emerging Markets: Laszlo Birinyi
- Pfizer Chomps On A Carrot
- Predictions 2010: Technology
MOST SHARED
- Keeping America Great
- Cisco Has 84% of Tandberg, Won't Extend Bid
- Kohlberg Kravis Bidding for Morgan Stanley's CICC Stake
- GE, Comcast Complete Deal Over NBC Universal: Source
- Australia Regulator Opposes Caltex-Exxon Deal
- Case Closed but Woods Scrutiny Continues
- UK Economy Turned, Inflation to Spike: BoE Economist
- Toyota Takes Lead Position in Canada in November
Text Size 
Analyst actions and clinical trial data were some of the catalysts behind the most actively traded stocks on Wednesday.
Shares of Bristol-Myers Squibb [BMY
Loading...
()
] rose after Citigroup upgraded the stock to "buy" from "hold" and said Wall Street is underestimating the company's ability to widen profit margins.
In addition, analyst George Grofik said consensus margin forecasts -- well below the industry average -- leave room for improvement as Plavix sales continue to grow. And while a potential takeover of Bristol has a low probability of happening, the analyst said, a deal would warrant a takeout price of about $35 to $40 a share.
"In light of recent weakness, we believe Bristol-Myers shares represent a compelling risk-reward proposition," said Grofik.
Ford Motor [MDVN
Loading...
()
] shares rose on news the automaker was selling its Jaguar and Land Rover brands. The Dearborn, Mich.-based company has suggested in the past that it would consider selling the two British brands, and on Tuesday said it was reviewing its position on them.
Network equipment maker Finisar [FNSR
Loading...
()
] reaffirmed its first-quarter revenue forecast on Tuesday after the close of trading, sending shares higher Wednesday. The company said during a conference call with analysts that it expects revenue of $105 million to $112 million in the first quarter. Analysts expect the Sunnyvale, Calif.-based company to post revenue of $107.3 million.
Lawson Software [LWSN
Loading...
()
] gained 7% on Wednesday after the business application software maker raised forecasts for the fourth quarter. Lawson raised its quarterly earnings estimate by 2 cents a share and raised revenue guidance above Wall Street expectations.
Among downside movers, HealthSpring [HS
Loading...
()
] fell on heavy trading volume after the managed healthcare provider cut 2007 earnings estimates, citing higher-than-expected medical service costs and facility charges.
Print
Email
- Will the Fed raise rates? Will the dollar continue its slide? CNBC experts weigh in on the year ahead.
- What may make this decade stand out are the extremes. After one of the worst global recessions ever, we take a look back.
- Goldman Sachs has forbidden employees from gathering in private holiday parties of 12 or more.
- Do you have what it takes to run your own business? Ask yourself these questions.
- Heavily armed pirates in Somalia have set up a sort of stock exhange to fund their hijackings.
- Since its launch in 1998, Google has become a primary force on the Internet. How much do you know about the company?
Data is a real-time snapshot *Data is delayed at least 15 minutes